President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
All content for The Commercial Awareness Compass by AllAboutLaw is the property of AllAboutLaw and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
Whose line is it anyway? AI’s copyright conundrum | Commercial Awareness Compass #42
The Commercial Awareness Compass by AllAboutLaw
31 minutes
3 months ago
Whose line is it anyway? AI’s copyright conundrum | Commercial Awareness Compass #42
Artificial intelligence is no longer a novelty. It is rewriting the rules of intellectual property. Established copyright principles are colliding with AI-generated creations, forcing governments, businesses and lawyers to question who owns what and who should bear the risk when things go wrong. Name, image and likeness rights, patents in biotech, and ownership of AI outputs are all live battlegrounds. The legal world is responding fast, with almost 1 in 10 new partners in UK law firms now w...
The Commercial Awareness Compass by AllAboutLaw
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
